VisszavonvaFázis nélkül
Adjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer Patients
A legfontosabb adatok
- Ki végzi
- The University of Texas Health Science Center at San Antonio
- Hol
- San Antonio (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Visszavonva
- Kezdés
- 2023. dec.
- Befejezés
- 2025. dec.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
- A vizsgált kezelések
- High Intensity Interval Training
- A regiszteradat frissítve
- 2024. február 26.
- Miért állt le
- PI left the institution, no subjects were enrolled
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Csak férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 26 feltétel megnézéseKevesebb
Ki vehet részt
- Diagnosis of metastatic prostate cancer; Includes metastatic hormone sensitive prostate cancer, AND; Metastatic castration resistant prostate cancer
- Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2
- Planned to receive docetaxel chemotherapy for treatment of prostate cancer with plan for at least 4 cycles of therapy
- Estimated life expectancy > 6 months
- Must be receiving androgen deprivation therapy (ADT) during study period or have had prior bilateral orchiectomy
- 4 weeks from any major surgery
- Age > 18 years
- Willing to participate in exercise intervention per protocol
- Cleared by study personnel to participate in exercise intervention based on screening physical exam
- Eligible patients can be participating in other investigational protocols or consent to other investigational protocols during this study participation if it does not affect docetaxel dosing, include additional cytotoxic chemotherapy, or interfere with exercise intervention
- Patients must be able to travel to one of the study-designated exercise facilities up to three days per week
- Required Initial Laboratory Values:; Absolute neutrophil count (12) ≥ 1500/uL; Platelet count ≥ 100,000/uL; Creatinine ≤ 1.5 x upper limits of normal; Bilirubin ≤ 1.5 x upper limits of normal; Aspartate aminotransferase (AST) ≤ 1.5 x upper limits of normal; Serum testosterone ≤ 50 ng/dL
Ki nem vehet részt
- Has already initiated first-line chemotherapy treatment course
- Receiving additional cytotoxic chemotherapy in addition to docetaxel during study participation
- Uncontrolled asthma (patient can participate if on asthma controlling medications and has access to rescue inhaler)
- Known small cell neuroendocrine cancer of the prostate
- Poorly controlled hypertension, BP >160/90 on >1 occasion during screening period
- NYHA Class II heart failure
- Serious cardiovascular event within 6 months of consent, including transient ischemic attack, cerebrovascular accident, or myocardial infarction
- Stable or unstable angina
- Active second malignancy, with exception of non-melanoma skin cancer or non-invasive bladder cancer
- Psychiatric illness, which would prevent the patient from giving informed consent or adhering to the study protocol
- Has chest pain during physical activity (patient can participate with cardiologist clearance)
- Known physical limitation that would impede participation in exercise per protocol
- Moderate-to-severe bone pain (i.e NCI common terminology criteria of adverse events grade 2-3 bone pain)
- Men already participating in vigorous aerobic exercise for more than 60 minutes per day or structured resistance exercise (>2 upper body and >2 lower body exercises) 2 or more days a week
Helyszínek itt: Egyesült Államok
- UT Health San AntonioSan Antonio, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study aims to examine the use of high-intensity interval training (HIIT) and resistance training on docetaxel chemotherapy tolerability and toxicity in metastatic prostate cancer.
A vizsgálat 2 csoportja
- Exercise InterventionA vizsgált kezelés
Participants will engage in 2-3 supervised high intensity aerobic and resistance exercise sessions per week.
Kezelés: High Intensity Interval Training
- ControlNincs vizsgálati kezelés, összehasonlításként
Participants will continue daily routine as usual and given an informational flyer on physical activity and cancer.
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Pilot Study of a Randomized Chemo-periodized Adjuvant High-Intensity Interval Training Intervention to Improve Chemotherapy Tolerance in Men With Metastatic Prostate Cancer
- A regiszteradat frissítve
- 2024. február 26.